Search - tctmd.com

Displaying 521 - 540 of 1527

Sort: Relevancy | Date

News Daily News

CMS Proposes Cuts to Cardiac CT Reimbursement, Provoking SCCT Ire

Yael L. Maxwell

August 26, 2019

News Daily News

Learning Curve for New CTO Operators: Some Reassurances, Some Caveats

L.A. McKeown

August 26, 2019

News Daily News

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

Michael O'Riordan

August 26, 2019

News Daily News

Late Follow-up of Surgical MV Repair: Insights for Timing, Innovation

Shelley Wood

August 20, 2019

News Daily News

No Volume-Outcome Link With Watchman for LAA Closure? Single-Center Study

Michael O'Riordan

August 19, 2019

News Features

Wearables Under the Microscope: How New Tech Will Disrupt Patient-Physician Dynamics

Marcus A. Banks

August 15, 2019

News Daily News

AHA Outlines Diagnosis, Treatment Options for Underrecognized Critical Limb Ischemia

Caitlin E. Cox

August 12, 2019

News Daily News

Echo Overuse in Heart Failure Stabilizes in the Wake of Ontario Appropriateness Efforts

Michael O'Riordan

August 09, 2019

News Daily News

CTO PCI Consensus Document Aims for Quality, Consistency but Acknowledges Data Gaps

Yael L. Maxwell

August 08, 2019

News Daily News

Same-Day Discharge After PCI Just as Safe as Overnight Stay, UK Study Finds

Marcus A. Banks

August 06, 2019

News Daily News

CEC Identifies ‘Prognostically Important’ MIs: CHAMPION PHOENIX

Michael O'Riordan

July 30, 2019

News Daily News

Endo-First Strategy Matches Surgery in Select CLI Patients: Retrospective Data

Caitlin E. Cox

July 30, 2019

News Daily News

Bleeding, Myocardial Injury Are Key Drivers of Deaths After Noncardiac Surgery

Michael O'Riordan

July 29, 2019

News Daily News

Nonobstructive CAD on Cardiac CTA a Golden Opportunity to Boost Statin Prescribing

Michael O'Riordan

July 22, 2019

News Daily News

Intensive Lipid-Lowering Slashes CVD in Elderly ACS Patients

Michael O'Riordan

July 19, 2019

News Conference News SCCT 2019

Doubling Down on SCOT-HEART: Mechanisms, Applicability, and Future Directions

Yael L. Maxwell

July 18, 2019

News Daily News

FDA Grants Cardiac MR Indication for Gadavist Contrast Injection

Shelley Wood

July 16, 2019

News Industry News

FDA approves Bayer's Gadavist® (gadobutrol) injection as the first and only contrast agent for use in cardiac MR in adult patients with known or suspected coronary artery disease

July 15, 2019

News Daily News

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Michael O'Riordan

July 10, 2019

News Daily News

Microvascular Disease Quadruples Risk of Leg Amputation

L.A. McKeown

July 08, 2019

Advertisement

CMS Proposes Cuts to Cardiac CT Reimbursement, Provoking SCCT Ire

Learning Curve for New CTO Operators: Some Reassurances, Some Caveats

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

Late Follow-up of Surgical MV Repair: Insights for Timing, Innovation

No Volume-Outcome Link With Watchman for LAA Closure? Single-Center Study

Wearables Under the Microscope: How New Tech Will Disrupt Patient-Physician Dynamics

AHA Outlines Diagnosis, Treatment Options for Underrecognized Critical Limb Ischemia

Echo Overuse in Heart Failure Stabilizes in the Wake of Ontario Appropriateness Efforts

CTO PCI Consensus Document Aims for Quality, Consistency but Acknowledges Data Gaps

Same-Day Discharge After PCI Just as Safe as Overnight Stay, UK Study Finds

CEC Identifies ‘Prognostically Important’ MIs: CHAMPION PHOENIX

Endo-First Strategy Matches Surgery in Select CLI Patients: Retrospective Data

Bleeding, Myocardial Injury Are Key Drivers of Deaths After Noncardiac Surgery

Nonobstructive CAD on Cardiac CTA a Golden Opportunity to Boost Statin Prescribing

Intensive Lipid-Lowering Slashes CVD in Elderly ACS Patients

Doubling Down on SCOT-HEART: Mechanisms, Applicability, and Future Directions

FDA Grants Cardiac MR Indication for Gadavist Contrast Injection

FDA approves Bayer's Gadavist® (gadobutrol) injection as the first and only contrast agent for use in cardiac MR in adult patients with known or suspected coronary artery disease

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Microvascular Disease Quadruples Risk of Leg Amputation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content